» Articles » PMID: 35717234

Cell Membrane-camouflaged Inorganic Nanoparticles for Cancer Therapy

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2022 Jun 18
PMID 35717234
Authors
Affiliations
Soon will be listed here.
Abstract

Inorganic nanoparticles (INPs) have been paid great attention in the field of oncology in recent past years since they have enormous potential in drug delivery, gene delivery, photodynamic therapy (PDT), photothermal therapy (PTT), bio-imaging, driven motion, etc. To overcome the innate limitations of the conventional INPs, such as fast elimination by the immune system, low accumulation in tumor sites, and severe toxicity to the organism, great efforts have recently been made to modify naked INPs, facilitating their clinical application. Taking inspiration from nature, considerable researchers have exploited cell membrane-camouflaged INPs (CMCINPs) by coating various cell membranes onto INPs. CMCINPs naturally inherit the surface adhesive molecules, receptors, and functional proteins from the original cell membrane, making them versatile as the natural cells. In order to give a timely and representative review on this rapidly developing research subject, we highlighted recent advances in CMCINPs with superior unique merits of various INPs and natural cell membranes for cancer therapy applications. The opportunity and obstacles of CMCINPs for clinical translation were also discussed. The review is expected to assist researchers in better eliciting the effect of CMCINPs for the management of tumors and may catalyze breakthroughs in this area.

Citing Articles

Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications.

Mao W, Yoo H Biomater Res. 2024; 28:0086.

PMID: 39323561 PMC: 11423863. DOI: 10.34133/bmr.0086.


Classification and application of metal-based nanoantioxidants in medicine and healthcare.

Nhat Nam N, Tran N, Nguyen T, Ngoc Trai N, Phuong Thuy N, Do H Beilstein J Nanotechnol. 2024; 15:396-415.

PMID: 38633767 PMC: 11022389. DOI: 10.3762/bjnano.15.36.


Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma.

Yang L, Li H, Luo A, Zhang Y, Chen H, Zhu L J Nanobiotechnology. 2024; 22(1):168.

PMID: 38610015 PMC: 11015647. DOI: 10.1186/s12951-024-02433-4.


Applications and Potentials of a Silk Fibroin Nanoparticle Delivery System in Animal Husbandry.

Guo Y, Awais M, Fei S, Xia J, Sun J, Feng M Animals (Basel). 2024; 14(4).

PMID: 38396623 PMC: 10885876. DOI: 10.3390/ani14040655.


Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.

Han X, Gong C, Yang Q, Zheng K, Wang Z, Zhang W Int J Nanomedicine. 2024; 19:571-608.

PMID: 38260239 PMC: 10802790. DOI: 10.2147/IJN.S442877.


References
1.
Azmi A, Bao B, Sarkar F . Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013; 32(3-4):623-42. PMC: 3843988. DOI: 10.1007/s10555-013-9441-9. View

2.
Shen S, Wang S, Zheng R, Zhu X, Jiang X, Fu D . Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation. Biomaterials. 2014; 39:67-74. DOI: 10.1016/j.biomaterials.2014.10.064. View

3.
Gong C, Yu X, You B, Wu Y, Wang R, Han L . Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. J Nanobiotechnology. 2020; 18(1):92. PMC: 7298843. DOI: 10.1186/s12951-020-00649-8. View

4.
Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X . Annual report on status of cancer in China, 2010. Chin J Cancer Res. 2014; 26(1):48-58. PMC: 3937758. DOI: 10.3978/j.issn.1000-9604.2014.01.08. View

5.
Pei W, Huang B, Chen S, Wang L, Xu Y, Niu C . Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer. Int J Nanomedicine. 2020; 15:10151-10167. PMC: 7754093. DOI: 10.2147/IJN.S285952. View